Radius Pharmaceuticals’ Tymlos will have to face highly competitive osteoporosis market despite positive results, says GlobalData
Radius Pharmaceuticals unveiled real-world evidence at the recently held World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases, demonstrating increased efficacy of Tymlos (abaloparatide) therapy in...